A recent market study indicates the Asia Pacific Fabry Disease Treatment Market is forecast to attain USD 1,088.17 million by 2034, expanding at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2034. This surge is propelled by heightened disease awareness, improved healthcare infrastructure, regulatory support for orphan drugs, and advanced...